Concepedia

Publication | Open Access

Phase II study of olaparib + durvalumab (MEDIOLA): Updated results in germline BRCA-mutated platinum-sensitive relapsed (PSR) ovarian cancer (OC)

DOIFull Paper Access

93

Citations

0

References

2019

Year

Yvette Drew, Bella Kaufman, Susana Banerjee, Alain Lortholary, Sook Hee Hong, Y.H. Park, Stefan Zimmermann, Patricia Roxburgh, Michelle Ferguson, Ricardo H. Álvarez,
Annals of Oncology

No additional data available for this publication yet. Check back later!